603127 Joinn Laboratories
- 15.34
- -0.09-0.58%
Joinn Laboratories News
Joinn Laboratories announces the progress of repurchasing company A shares through centralized bidding trading.
Announcement of Joinn Laboratories regarding the adjustment of the repurchase share price limit after the implementation of the A-share equity distribution in 2023.
Implementation Announcement of A-share Equity Distribution for 2023 by Joinn Laboratories Co., Ltd. in Peking
Joinn Laboratories Announcement on the Implementation of the Share Buyback Cancellation for Part of the Restricted Stock Incentive Plan for A-share in 2021.
Joinn Laboratories announces the progress of repurchasing company A shares through centralized bidding trading.
Announcement of the expiration of the shareholder shareholding reduction plan and the shareholding reduction results of Joinn Laboratories.
Joinn Laboratories announces the progress of repurchasing company A shares through centralized bidding trading.
Announcement of Zhaoyan Pharmaceutical's Notice to Creditors on Repurchase and Cancellation of Some Restricted Shares
Announcement of Zhaoyan Pharmaceutical on the initial repurchase of the company's A-share shares through centralized bidding transactions and the progress of the repurchase
Zhaoyan Pharmaceutical's announcement on the progress of repurchasing the company's A-share shares through centralized bidding transactions
Announcement of the 2023 Profit Distribution Plan of Beijing Zhaoyan Pharmaceutical Research Center Co., Ltd.
Report on the repurchase of the company's A-share shares through centralized bidding transactions by Zhaoyan New Pharmaceutical
Announcement of Zhaoyan Pharmaceutical's Notice to Creditors on Repurchase and Cancellation of Some Restricted Shares
Zhaoyan Pharmaceutical\'s indicative announcement on receiving the chairman\'s proposal to repurchase the company\'s A-share shares and promote a plan to “improve quality, increase efficiency, and focus on return”
Announcement of Zhaoyan New Pharmaceutical\'s shareholders\' plan to reduce their A-share holdings
Announcement of Zhaoyan New Pharmaceutical on the release of the pledge of shareholders\' shares
Announcement of the expiration of the shareholders\' and directors\' supervisors\' holdings reduction plan of Zhaoyan New Pharmaceuticals and the results of the holdings reduction
Zhaoyan New Pharmaceutical\'s Announcement on Cancelling Some Stock Options in the 2018, 2019 and 2020 Equity Incentive Plans
Announcement of Zhaoyan New Pharmaceutical on the adjustment of the number of benefits granted by the 2021 A-share Restricted Stock Incentive Plan and the repurchase price
Zhaoyan New Pharmaceutical\'s Announcement on Termination of Implementation of the 2021 A-Share Restricted Stock Incentive Plan and Repurchase and Cancellation of Related Restricted Stocks
Analysis
Price Target
No Data
